Resource Science: Biologics

Enhancing Biopharmaceutical Manufacturing with Single-Use Bioreactors: A Transformative Solution for CRDMO Operations

Integrated Cell Line Development Solutions

A Comparative Efficiency Analysis of Commercial Transfection Reagents in HEK 293 Cells

Aragen protein science solutions: Industry leading upstream and downstream capabilities

Comprehensive Characterization of Biologics

An optimal upstream process development approach to increase the titers of the monoclonal antibodies (mAbs)

Industry Leading Hybridoma Technique for Accelerated Antibody Discovery

Mitigating CMC issues through Aragen’s holistic approach to developability assessment

Cell Line Development at Aragen: Research cell banks in 5 months

Accelerating Biologics Development to Medicines: Key Drivers of Success